Background/Aims: Accurate risk stratification is important in the management of patients with acute myocardial infarction (AMI). This study aimed to develop a new assessment tool for the prediction of 1-year mortality in patients with AMI, including biochemical markers. The author developed a new assessment tool (new risk score) that takes biochemical markers into account for 1-year mortality in patients with non-ST elevation myocardial infarction (NSTEMI) and identifies the risk factors related to 1-year mortality. Methods: A total of 1,427 patients (65 ± 11.8 years of age, 985 males) who were admitted to the Chonnam National University Hospital with NSTEMI from November 2005 to March 2012 were retrospectively analyzed for score derivation. Multivariable Cox-regression analysis was used to select correlates of 1-year mortality that were subsequently weighted and integrated into an integer scoring system. Results: Seven variables selected from the initial multivariate model were weighted proportionally to their respective hazard ratio
연구 종료점 Values are presented as number (%) or mean ± standard deviation. Values are presented as number (%) or mean ± standard deviation. Values are presented as number (%) or mean ± standard deviation. TIMI, thrombolysis in myocardial infarction; PCI, percutaneous coronary intervention. Anemia was defined as Hb < 13 mg/dL in males, Hb < 12 mg/dL in females. 중심 단어: 급성 심근경색증; 사망률; 예후
